Introduction of human papillomavirus (HPV) vaccination in Sweden.
The Swedish National Board of Health and Welfare (NBH) decided that a vaccine that protects against cervical cancer caused by human papillomavirus (HPV) should be included in the childhood vaccination directive as a nationwide-programme targeting 12-year-old girls from 2010 as a part of the school-health programme. Currently, vaccination of girls 13-18 years of age is covered by the public insurance. In this paper we describe the decision-making process behind the introduction of HPV vaccination in Sweden.
Tegnell
A
A
The National Board of Health and Welfare (Socialstyrelsen), Stockholm, Sweden. Anders.Tegnell@socialstyrelsen.se
Dillner
J
J
Andrae
B
B
D000293:Adolescent; D004196:Disease Outbreaks / Q000517:prevention & control / Q000706:statistics & numerical data; D005260:Female; D006291:Health Policy / Q000639:trends*; D006801:Humans; D032541:Mass Vaccination / Q000379:methods* / Q000458:organization & administration*; D009313:National Health Programs / Q000458:organization & administration*; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D013548:Sweden / Q000453:epidemiology
D053918:Papillomavirus Vaccines